There is No Randomized Data for TCAR: Transfemoral Stenting Remains a Viable Option | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

NY Endovascular Summit

There is No Randomized Data for TCAR: Transfemoral Stenting Remains a Viable Option

By NY Endovascular Summit FEATURING Kenneth Rosenfield

By NY Endovascular Summit FEATURING Kenneth Rosenfield

186 views

November 29, 2022

Comments 0

Login to view comments. Click here to Login